197 related articles for article (PubMed ID: 37503329)
1. Engineered exosomes targeting MYC reverse the proneural-mesenchymal transition and extend survival of glioblastoma.
Haltom AR; Hassen WE; Hensel J; Kim J; Sugimoto H; Li B; McAndrews KM; Conner MR; Kirtley ML; Luo X; Xie B; Volpert OV; Olalekan S; Maltsev N; Basu A; LeBleu VS; Kalluri R
Extracell Vesicle; 2022 Dec; 1():. PubMed ID: 37503329
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic targeting of STAT3 with small interference RNAs and antisense oligonucleotides embedded exosomes in liver fibrosis.
Tang M; Chen Y; Li B; Sugimoto H; Yang S; Yang C; LeBleu VS; McAndrews KM; Kalluri R
FASEB J; 2021 May; 35(5):e21557. PubMed ID: 33855751
[TBL] [Abstract][Full Text] [Related]
3. Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44.
Rimkus TK; Carpenter RL; Sirkisoon S; Zhu D; Pasche BC; Chan MD; Lesser GJ; Tatter SB; Watabe K; Debinski W; Lo HW
Cancer Res; 2018 May; 78(10):2589-2600. PubMed ID: 29463580
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.
Luedi MM; Singh SK; Mosley JC; Hassan ISA; Hatami M; Gumin J; Andereggen L; Sulman EP; Lang FF; Stueber F; Fuller GN; Colen RR; Zinn PO
J Neurosurg; 2018 Dec; 129(6):1446-1455. PubMed ID: 29328002
[TBL] [Abstract][Full Text] [Related]
5. ME2 Promotes Proneural-Mesenchymal Transition and Lipogenesis in Glioblastoma.
Yang M; Chen X; Zhang J; Xiong E; Wang Q; Fang W; Li L; Fei F; Gong A
Front Oncol; 2021; 11():715593. PubMed ID: 34381734
[TBL] [Abstract][Full Text] [Related]
6. TAK-242 inhibits glioblastoma invasion, migration, and proneural-mesenchymal transition by inhibiting TLR4 signaling.
Feng Z; Chen G; Huang Y; Zhang K; Wu G; Xing W; Wu Y; Zhou Y; Sun C
Exp Cell Res; 2024 May; 439(1):114091. PubMed ID: 38740168
[TBL] [Abstract][Full Text] [Related]
7. Glioblastoma genetic drivers dictate the function of tumor-associated macrophages/microglia and responses to CSF1R inhibition.
Rao R; Han R; Ogurek S; Xue C; Wu LM; Zhang L; Zhang L; Hu J; Phoenix TN; Waggoner SN; Lu QR
Neuro Oncol; 2022 Apr; 24(4):584-597. PubMed ID: 34562087
[TBL] [Abstract][Full Text] [Related]
8. The landscape of the mesenchymal signature in brain tumours.
Behnan J; Finocchiaro G; Hanna G
Brain; 2019 Apr; 142(4):847-866. PubMed ID: 30946477
[TBL] [Abstract][Full Text] [Related]
9. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
[TBL] [Abstract][Full Text] [Related]
11. Integration analysis of single-cell and spatial transcriptomics reveal the cellular heterogeneity landscape in glioblastoma and establish a polygenic risk model.
Liu Y; Wu Z; Feng Y; Gao J; Wang B; Lian C; Diao B
Front Oncol; 2023; 13():1109037. PubMed ID: 37397378
[TBL] [Abstract][Full Text] [Related]
12. EGFRvIII Promotes the Proneural-Mesenchymal Transition of Glioblastoma Multiforme and Reduces Its Sensitivity to Temozolomide by Regulating the NF-κB/ALDH1A3 Axis.
Shi ZF; Li GZ; Zhai Y; Pan CQ; Wang D; Yu MC; Liu C; Zhang W; Yu XG
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980923
[TBL] [Abstract][Full Text] [Related]
13. Monocyte depletion enhances neutrophil influx and proneural to mesenchymal transition in glioblastoma.
Chen Z; Soni N; Pinero G; Giotti B; Eddins DJ; Lindblad KE; Ross JL; Puigdelloses Vallcorba M; Joshi T; Angione A; Thomason W; Keane A; Tsankova NM; Gutmann DH; Lira SA; Lujambio A; Ghosn EEB; Tsankov AM; Hambardzumyan D
Nat Commun; 2023 Apr; 14(1):1839. PubMed ID: 37012245
[TBL] [Abstract][Full Text] [Related]
14. CDK4/6 inhibition is more active against the glioblastoma proneural subtype.
Li M; Xiao A; Floyd D; Olmez I; Lee J; Godlewski J; Bronisz A; Bhat KPL; Sulman EP; Nakano I; Purow B
Oncotarget; 2017 Aug; 8(33):55319-55331. PubMed ID: 28903422
[TBL] [Abstract][Full Text] [Related]
15. Umbilical cord blood-derived mesenchymal stem cells inhibit, but adipose tissue-derived mesenchymal stem cells promote, glioblastoma multiforme proliferation.
Akimoto K; Kimura K; Nagano M; Takano S; To'a Salazar G; Yamashita T; Ohneda O
Stem Cells Dev; 2013 May; 22(9):1370-86. PubMed ID: 23231075
[TBL] [Abstract][Full Text] [Related]
16. Targeting the mesenchymal subtype in glioblastoma and other cancers via inhibition of diacylglycerol kinase alpha.
Olmez I; Love S; Xiao A; Manigat L; Randolph P; McKenna BD; Neal BP; Boroda S; Li M; Brenneman B; Abounader R; Floyd D; Lee J; Nakano I; Godlewski J; Bronisz A; Sulman EP; Mayo M; Gioeli D; Weber M; Harris TE; Purow B
Neuro Oncol; 2018 Jan; 20(2):192-202. PubMed ID: 29048560
[TBL] [Abstract][Full Text] [Related]
17. Temozolomide suppresses MYC via activation of TAp63 to inhibit progression of human glioblastoma.
Yamaki T; Suenaga Y; Iuchi T; Alagu J; Takatori A; Itami M; Araki A; Ohira M; Inoue M; Kageyama H; Yokoi S; Saeki N; Nakagawara A
Sci Rep; 2013; 3():1160. PubMed ID: 23362460
[TBL] [Abstract][Full Text] [Related]
18. The E3 ubiquitin ligase HUWE1 acts through the N-Myc-DLL1-NOTCH1 signaling axis to suppress glioblastoma progression.
Yuan Y; Wang LH; Zhao XX; Wang J; Zhang MS; Ma QH; Wei S; Yan ZX; Cheng Y; Chen XQ; Zou HB; Ge J; Wang Y; Zhang X; Cui YH; Luo T; Bian XW
Cancer Commun (Lond); 2022 Sep; 42(9):868-886. PubMed ID: 35848447
[TBL] [Abstract][Full Text] [Related]
19. PBX3/MEK/ERK1/2/LIN28/let-7b positive feedback loop enhances mesenchymal phenotype to promote glioblastoma migration and invasion.
Xu X; Bao Z; Liu Y; Jiang K; Zhi T; Wang D; Fan L; Liu N; Ji J
J Exp Clin Cancer Res; 2018 Jul; 37(1):158. PubMed ID: 30016974
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between glioblastoma and tumor microenvironment drives proneural-mesenchymal transition through ligand-receptor interactions.
Lai Y; Lu X; Liao Y; Ouyang P; Wang H; Zhang X; Huang G; Qi S; Li Y
Genes Dis; 2024 Mar; 11(2):874-889. PubMed ID: 37692522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
